Triple

T1351618
Position Surface form Disambiguated ID Type / Status
Subject Fampyra E28893 entity
Predicate riskManagementPlanRequiredBy P8851 FINISHED
Object European Medicines Agency E3950 NE FINISHED

How this triple was built (3 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Medicines Agency | Statement: [Fampyra, riskManagementPlanRequiredBy, European Medicines Agency]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: European Medicines Agency
Context triple: [Fampyra, riskManagementPlanRequiredBy, European Medicines Agency]
  • A. European Medicines Agency chosen
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • B. Committee for Medicinal Products for Human Use
    The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
  • C. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • D. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • E. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: riskManagementPlanRequiredBy
Context triple: [Fampyra, riskManagementPlanRequiredBy, European Medicines Agency]
  • A. riskManagement
    Indicates the implementation of strategies and actions to identify, assess, and mitigate potential risks associated with an entity or activity.
  • B. riskManagedBy
    Indicates that the potential or identified risk is controlled, mitigated, or overseen through the actions, policies, or responsibilities of a specified managing entity.
  • C. riskIfNoncompliance
    Indicates that a risk or negative consequence will occur if the specified rules, requirements, or obligations are not complied with.
  • D. hasManagementPlan chosen
    Indicates that an entity is associated with a defined management plan specifying how it should be overseen, maintained, or administered.
  • E. marginRequirement
    Indicates the minimum amount of collateral or equity that must be maintained to support a position or transaction, typically expressed as a percentage of the position’s value.
  • F. None of above.

Provenance (4 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a498571d248190a0ac9eb02d97097f completed March 1, 2026, 7:49 p.m.
NER Named-entity recognition batch_69a4c26b1b4881908ae4b1b2c9b268a0 completed March 1, 2026, 10:49 p.m.
NED1 Entity disambiguation (via context triple) batch_69ad36f900848190bb00cd7ad8eada60 completed March 8, 2026, 8:44 a.m.
PD Predicate disambiguation batch_69a4bef5857c81909ae984feb85a26ca completed March 1, 2026, 10:34 p.m.
Created at: March 1, 2026, 7:56 p.m.